Amide proton transfer MR imaging in the characterization of brain tumors: A review paper DOI Creative Commons

Yu Ying,

Noorazrul Yahya, Hanani Abdul Manan

и другие.

Journal of Radiation Research and Applied Sciences, Год журнала: 2024, Номер 17(3), С. 101043 - 101043

Опубликована: Июль 29, 2024

Amide proton transfer (APT) magnetic resonance imaging (MR) is a new technology that has shown promise in the non-invasive characterization of brain malignancies, particularly meningiomas and glioblastomas. Th works aims to evaluate existing literature explore efficacy APT MR glioblastomas tumors. The review gives an overview principles, examines its potential benefits limits, highlights important findings from selected research. To discover relevant research published up current day, search was undertaken electronic databases such as PubMed Google Scholar. based on keywords medical terms related imaging, meningiomas, It showed majority studies found encouraging results distinguishing surrounding normal tissue using imaging. For tumor characterization, signal intensity assessments asymmetry analysis ratio were used. work concluded be method for diagnosis provides useful information about metabolism cellular composition, which can help with diagnosis, therapy planning, prognosis.

Язык: Английский

Biomarker-driven molecular imaging probes in radiotherapy DOI Creative Commons
Haonan Li, Qiyong Gong, Kui Luo

и другие.

Theranostics, Год журнала: 2024, Номер 14(10), С. 4127 - 4146

Опубликована: Янв. 1, 2024

Biomarker-driven molecular imaging has emerged as an integral part of cancer precision radiotherapy. The use probes, including nanoprobes, have been explored in radiotherapy to precisely and noninvasively monitor spatiotemporal distribution biomarkers, potentially revealing tumor-killing mechanisms therapy-induced adverse effects during radiation treatment.

Язык: Английский

Процитировано

75

Stimuli-Responsive Polymeric Nanocarriers Accelerate On-Demand Drug Release to Combat Glioblastoma DOI
Muhammad Ismail,

Yibin Wang,

Y. M. Li

и другие.

Biomacromolecules, Год журнала: 2024, Номер unknown

Опубликована: Сен. 11, 2024

Glioblastoma multiforme (GBM) is a highly malignant brain tumor with poor prognosis and limited treatment options. Drug delivery by stimuli-responsive nanocarriers holds great promise for improving the modalities of GBM. At beginning review, we highlighted stimuli-active polymeric carrying therapies that potentially boost anti-GBM responses employing endogenous (pH, redox, hypoxia, enzyme) or exogenous stimuli (light, ultrasonic, magnetic, temperature, radiation) as triggers controlled drug release mainly via hydrophobic/hydrophilic transition, degradability, ionizability, etc. Modifying these target ligands further enhanced their capacity to traverse blood-brain barrier (BBB) preferentially accumulate in glioma cells. These unique features lead more effective cancer minimal adverse reactions superior therapeutic outcomes. Finally, review summarizes existing difficulties future prospects treating Overall, this offers theoretical guidelines developing intelligent versatile facilitate precise GBM clinical settings.

Язык: Английский

Процитировано

7

Drug resistance in human cancers — Mechanisms and implications DOI

Sudikshaa Vijayakumar,

Raveena Dhakshanamoorthy,

Akshaya Baskaran

и другие.

Life Sciences, Год журнала: 2024, Номер 352, С. 122907 - 122907

Опубликована: Июль 14, 2024

Язык: Английский

Процитировано

5

Zero-Crosstalk Tumor-Targeting Ratiometric Near-Infrared γ-Glutamyltranspeptidase Probe for Fluorescent-Guided Surgical Resection of Orthotopic Hepatic Tumor DOI
Zhichao Yang,

ZhiHao Yang,

Zhiqiang Wang

и другие.

Analytical Chemistry, Год журнала: 2025, Номер unknown

Опубликована: Янв. 3, 2025

The challenge of "false positive" signals significantly complicates tumor localization and surgical resection, which are pivotal for successful surgeries. Therefore, the development a method preoperative intraoperative margin determination holds considerable promise improving outcomes. In this study, zero-crosstalk ratiometric tumor-targeting near-infrared (NIR) fluorescent probe was developed precise cancer diagnosis navigation via NIR fluorescence imaging. This integrates moiety that selectively homes in on hepatocellular carcinoma cells exhibits highly sensitive response to γ-glutamyltranspeptidase (GGT), characterized by substantial emission shift from 830 650 nm. unique property enhances its effectiveness early imaging-guided surgery resection. Furthermore, successfully monitors GGT activity blood, cells, vivo, endowing potential clinic. Due efficient targeting situ both subcutaneous tumors orthotopic hepatic tumors, accurate detection capability tumors. Additionally, leveraging imaging, can serve as sprayable tool delineating margins with precision, thereby furnishing real-time imaging guidance during resection surgery.

Язык: Английский

Процитировано

0

Hierarchical Targeting Nanoplatform for NIR‐II Photoacoustic Imaging and Photo‐Activated Synergistic Immunotherapy of Glioblastoma DOI Open Access
Yuan Zhang, Xiaoying Kang, Jingyi Ma

и другие.

Advanced Functional Materials, Год журнала: 2025, Номер unknown

Опубликована: Март 24, 2025

Abstract Glioblastoma (GBM) stands as the most aggressive malignant brain tumor, characterized by poor prognosis, high recurrence rate, and resistance to multiple therapies, posing a significant clinical challenge. Here, hierarchical targeting platform is presented for NIR‐II photoacoustic (PA) imaging‐guided photo‐chemo synergistic immunotherapy of GBM. A new molecular probe developed with exceptional light‐harvesting capabilities enhanced motion, boosting both photothermal conversion PA signal. This probe, combined thermo‐responsive prodrug, assembled into nanoparticles that are further camouflaged tumor cell membranes bioorthogonally modified transferrin‐mimicking peptide, facilitating blood‐brain barrier penetration GBM targeting. High‐contrast imaging allows precise detection delineation GBM, providing accurate guidance subsequent treatment. The light‐triggered effect, coupled hyperthermia‐activated significantly induces immunogenic death, enhancing tumor‐killing efficiency amplifying anti‐tumor immune response. self‐synergistic not only stimulates robust immunity inhibits primary growth but also prevents post‐surgical recurrence, prolonging survival time. work exemplifies novel paradigm tackling diagnostic therapeutic challenges posed deeply seated poorly tumors.

Язык: Английский

Процитировано

0

Exploit the γ-Glutamyl hydroxymethyl rhodamine green fluorescence in surgical resection: A systematic literature review on clinical indications, fields of application and outcomes DOI

Salvatore Marrone,

Gianluca Scalia, Oday Atallah

и другие.

Neurosurgical Review, Год журнала: 2025, Номер 48(1)

Опубликована: Март 28, 2025

Язык: Английский

Процитировано

0

Promoting mitocytosis via gene-engineered aligned fibers for fascia regeneration DOI

Yiru Xu,

Qimanguli Saiding, Xue Zhou

и другие.

Journal of Controlled Release, Год журнала: 2025, Номер unknown, С. 113725 - 113725

Опубликована: Апрель 1, 2025

Язык: Английский

Процитировано

0

Chondrocyte Mitochondrial Quality Control: A Novel Insight into Osteoarthritis and Cartilage Regeneration DOI

Jinni Wu,

XU Jiawen,

Menghan Zhang

и другие.

Advances in Wound Care, Год журнала: 2025, Номер unknown

Опубликована: Апрель 18, 2025

Significance: Osteoarthritis (OA), one of the most prevalent joint diseases affecting more than 240 million people, strongly influences human health and reduces life quality. This review aims to fill current research gap regarding application potential mitochondrial quality control (MQC) based therapies in treatment OA, thereby providing guidance for future clinical practice. Recent Advances: Chondrocytes respond inflammatory microenvironment via an array signaling pathways thus are critical cartilage degeneration OA progression. Mitochondria, as important metabolic center chondrocytes, play a vital role responding stimuli. Multiple MQC mechanisms, including antioxidant defense, protein control, DNA repair, dynamics, mitophagy, biogenesis, sustain homeostasis under pathological conditions. Critical Issues: Despite extensive research, effective remain limited. Elucidating mechanisms disease progression post-traumatic repair is crucial. While preclinical studies demonstrate potential, translation requires addressing protocol standardization, patient stratification, long-term efficacy, well safety validation. Future Directions: should focus on developing personalized MQC-based guided by biomarker profiling pathway modulation. However, translational challenges persist, particularly pervasive off-target effects, inadequate OA-specific targeting capacity, interpatient heterogeneity, reliable evaluation therapeutic efficacy. Strategic prioritization targets coupled with delivery system optimization may significantly improve both translatability outcomes.

Язык: Английский

Процитировано

0

Harnessing and Mimicking Bacterial Features to Combat Cancer: From Living Entities to Artificial Mimicking Systems DOI
Peng Gao, Zhenyu Duan, Gang Xu

и другие.

Advanced Materials, Год журнала: 2024, Номер 36(35)

Опубликована: Авг. 1, 2024

Bacterial-derived micro-/nanomedicine has garnered considerable attention in anticancer therapy, owing to the unique natural features of bacteria, including specific targeting ability, immunogenic benefits, physicochemical modifiability, and biotechnological editability. Besides, bacterial components have also been explored as promising drug delivery vehicles. Harnessing these features, cutting-edge biotechnologies applied attenuated tumor-targeting bacteria with properties or functions for potent effective cancer treatment, strategies gene-editing genetic circuits. Further, advent bacteria-inspired micro-/nanorobots mimicking artificial systems furnished fresh perspectives formulating developing highly efficient systems. Focusing on advantages this review delves into advances bacteria-derived treatment recent years, which experienced a process from living entities Meanwhile, summary relative clinical trials is provided primary challenges impeding their application are discussed. Furthermore, future directions suggested combat cancer.

Язык: Английский

Процитировано

2

Miro-mediated mitochondrial transport: A new dimension for disease-related abnormal cell metabolism? DOI

Yanxing Li,

Zhen Yang,

Shumei Zhang

и другие.

Biochemical and Biophysical Research Communications, Год журнала: 2024, Номер 705, С. 149737 - 149737

Опубликована: Фев. 28, 2024

Язык: Английский

Процитировано

1